This is a StreetInsider.com Premium Only Page

BioMarin Pharma (BMRN) – Hot FDA News

Jun 29, 2023 02:36 PM BioMarin Pharma (BMRN) Announces FDA Approves ROCTAVIAN, the First and Only Gene Therapy for Adults with Severe Hemophilia A

Nov 23, 2022 08:31 AM BioMarin Pharma (BMRN) says FDA no longer plans to hold an advisory committee meeting to discuss the BLA for ROCTAVIAN for Adults with Severe Hemophilia A

Jan 10, 2022 05:48 AM

Nov 19, 2021 10:33 AM

Sep 7, 2021 06:45 AM

Aug 19, 2020 08:02 AM

Dec 16, 2019 08:16 AM

May 28, 2019 06:58 AM

Dec 22, 2017 08:31 AM

Dec 19, 2017 04:06 PM

Dec 11, 2017 06:13 AM

Nov 27, 2017 08:46 AM

Jun 30, 2017 09:12 AM

Nov 25, 2015 06:37 AM

Nov 20, 2015 07:59 AM

Aug 19, 2015 04:09 PM

Jun 29, 2015 08:31 AM

Jan 12, 2015 01:48 PM

Feb 14, 2014 03:21 PM

Jan 8, 2014 08:09 AM

Nov 19, 2013 04:08 PM

Nov 19, 2013 03:58 PM